Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

ISRG

Intuitive Surgical Inc

Apr 20 • 04:00PM ET

465.60

-3.61 -0.77 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Today, 4:30 AMIntuitive Surgical Inc is scheduled to announce earnings today after market close. Analysts expect non-GAAP EPS of $2.12 and revenue of $2.6B

Peers: MDT SYK ABT JNJ BSX EW ZBH GMED TMDX

| Held by: VTI VOO QQQ IVV SPY VUG XLV IWF QQQM IHI

Index	NDX, S&P 500	P/E	59.12	EPS (ttm)	7.88	Insider Own	0.64%	Shs Outstand	355.10M	Perf Week	1.45%
Market Cap	165.37B	Forward P/E	40.81	EPS next Y	11.41	Insider Trans	-6.41%	Shs Float	352.90M	Perf Month	-2.99%
Enterprise Value	159.72B	PEG	3.01	EPS next Q	2.12	Inst Own	85.67%	Short Float	1.91%	Perf Quarter	-12.97%
Income	2.86B	P/S	16.43	EPS this Y	11.90%	Inst Trans	0.33%	Short Ratio	3.51	Perf Half Y	7.13%
Sales	10.06B	P/B	9.28	EPS next Y	14.17%	ROA	14.47%	Short Interest	6.75M	Perf YTD	-17.79%
Book/sh	50.19	P/C	27.86	EPS next 5Y	13.56%	ROE	16.67%	52W High	603.88 -22.90%	Perf Year	-3.55%
Cash/sh	16.71	P/FCF	66.39	EPS past 3/5Y	29.18% 21.79%	ROIC	15.91%	52W Low	427.84 8.83%	Perf 3Y	56.55%
Dividend Est.	-	EV/EBITDA	44.70	Sales past 3/5Y	17.39% 18.22%	Gross Margin	65.98%	Volatility	2.52% 2.36%	Perf 5Y	72.21%
Dividend TTM	-	EV/Sales	15.87	EPS Y/Y TTM	22.44%	Oper. Margin	29.27%	ATR (14)	12.18	Perf 10Y	550.12%
Dividend Ex-Date	-	Quick Ratio	3.96	Sales Y/Y TTM	20.51%	Profit Margin	28.38%	RSI (14)	48.19	Recom	1.92
Dividend Gr. 3/5Y	- -	Current Ratio	4.87	EPS Q/Q	17.04%	SMA20	0.86%	Beta	1.56	Target Price	597.35
Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	18.76%	SMA50	-2.91%	Rel Volume	1.27	Prev Close	469.21
Employees	17021	LT Debt/Eq	0.01	Earnings	Apr 21 AMC	SMA200	-7.38%	Avg Volume	1.92M	Price	465.60
IPO	Jun 13, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.58% 3.75%	Trades		Volume	2,441,890	Change	-0.77%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-11-26	Upgrade	Citigroup	Neutral → Buy	$590
Jan-27-26	Initiated	TD Cowen	Buy	$660
Dec-11-25	Downgrade	Citigroup	Buy → Neutral	$635
Jul-23-25	Downgrade	Erste Group	Buy → Hold
Jun-09-25	Downgrade	Deutsche Bank	Hold → Sell	$440
Jun-05-25	Upgrade	Erste Group	Hold → Buy
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$522 → $650
Aug-02-24	Upgrade	Redburn Atlantic	Neutral → Buy	$380 → $510
Jul-10-24	Reiterated	Citigroup	Buy	$462 → $512
May-30-24	Initiated	Goldman	Buy	$500
Nov-17-23	Initiated	HSBC Securities	Buy	$318
Jul-19-23	Initiated	Robert W. Baird	Outperform	$377
Apr-19-23	Reiterated	Wells Fargo	Overweight	$289 → $310
Apr-19-23	Reiterated	Truist	Buy	$300 → $325
Apr-19-23	Reiterated	Stifel	Buy	$285 → $315
Apr-19-23	Reiterated	RBC Capital Mkts	Outperform	$305 → $309
Apr-19-23	Reiterated	Raymond James	Outperform	$270 → $323
Apr-19-23	Reiterated	Morgan Stanley	Equal-Weight	$265 → $285
Apr-19-23	Reiterated	JP Morgan	Overweight	$250 → $335
Apr-19-23	Reiterated	Evercore ISI	In-line	$240 → $270

Show Previous Ratings

Apr-09-26 08:11PM	Can 13-15% Procedure Growth in 2026 Sustain ISRG's Premium Valuation? (Quartz)
Apr-08-26 09:31AM	Tired of AI and Oil? Buy the Robot. (Trefis)
Apr-03-26 07:38AM	Restore Robotics cleared to remanufacture 2 more da Vinci Xi instruments (MedTech Dive)
Mar-31-26 06:30AM	Can Boston Scientific Stock Surge 40% From Here? (Trefis)
Mar-24-26 11:03AM	Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems (PR Newswire)
01:01AM	Loading…
Mar-23-26 01:01AM	ISRG- Not Cheap, But Delivering on Growth Expectations (MoneyShow)
Mar-13-26 02:38PM	Intuitive Surgical Stock Falls After Cybersecurity Breach Hits Internal Systems (GuruFocus.com)
11:47AM	Intuitive Surgical hit by phishing incident (MedTech Dive)
Mar-11-26 09:40AM	Oracle, Nike upgraded: Wall Street's top analyst calls (The Fly)
07:45AM	Here Are Wednesday's Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More (24/7 Wall St.)
05:20AM	Citi upgrades Intuitive Surgical to Buy on recent selloff (TipRanks)
05:10AM	Intuitive Surgical upgraded to Buy from Neutral at Citi (TipRanks)
Mar-10-26 01:39PM	Stryker Introduces SmartHospital Platform to Advance Connected Care (Zacks)
01:11PM	GEHC Wins FDA 510(k) Approval for View, Enhances Radiology Workflows (Zacks)
10:55AM	Here's Why You Should Retain CONMED Stock in Your Portfolio Now (Zacks)
09:34AM	Loading…
09:34AM	5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside (Zacks)
09:05AM	National Vision Gains 129.5% in a Year: What's Driving the Rally? (Zacks)
08:24AM	Should You Continue to Hold DGX Stock in Your Portfolio? (Zacks)
05:36AM	Intuitive Surgical, Inc. (ISRG) Announces the Completion of its Acquisition of the da Vinci and Ion Distribution Business (Insider Monkey)
02:48AM	SS Innovations raises $18.6M as surgical robot nears US market (MedTech Dive)
Mar-09-26 01:03PM	IDEXX Laboratories Stock Climbs 39.4% in a Year: What's Driving It? (Zacks)
11:53AM	Novocure's Optune Lua Gets Japan Reimbursement for NSCLC Treatment (Zacks)
09:30AM	Intuitive Surgical (ISRG) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
12:43AM	2 Healthcare Stocks with Exciting Potential and 1 We Avoid (StockStory)
Mar-06-26 05:50PM	Intuitive Surgical, Inc. (ISRG) Stock Moves -1.32%: What You Should Know (Zacks)
11:49AM	Here's Why You Should Add DaVita Stock to Your Portfolio for Now (Zacks)
11:44AM	BDX Secures CE Mark for Revello Stent to Treat Iliac Artery Disease (Zacks)
Mar-05-26 01:00PM	Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates (Zacks)
12:46PM	BD Gains FDA Clearance for Surgiphor 1000mL Surgical Irrigation System (Zacks)
09:33AM	Here's Why You Should Retain INSP Stock in Your Portfolio for Now (Zacks)
09:31AM	Loading…
09:31AM	RGTI Stock Down Despite Q4 Earnings Top Estimates, Revenues Decline Y/Y (Zacks)
07:43AM	EYE Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
Mar-04-26 12:30PM	Here's Why You Should Retain Clover Stock in Your Portfolio for Now (Zacks)
10:50AM	Stryker Unveils Next-Gen Orthopedic Innovations at AAOS 2026 (Zacks)
09:00AM	This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Mar-03-26 08:15AM	Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026? (Zacks)
06:42AM	BOTZ Is A Robotics ETF That Quietly Bets Big on AI Chips (24/7 Wall St.)
Mar-02-26 12:59PM	OGN's VTAMA Cream Shows Sleep Benefits in Pediatric Atopic Dermatitis (Zacks)
12:13PM	5 Stocks Racing Ahead as AI Supercharges Robotics (MarketBeat)
09:00AM	Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock (Zacks)
07:41AM	PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
07:41AM	Integra Q4 Earnings & Revenues Beat Estimates, Margins Down, Stock Up (Zacks)
07:00AM	Intuitive Expands Investment and Footprint in Europe (GlobeNewswire)
06:27AM	Intuitive expands in Europe with purchase of distributor operations (MedTech Dive)
Mar-01-26 10:37PM	A Look Back at Surgical Equipment & Consumables - Specialty Stocks' Q4 Earnings: Intuitive Surgical (NASDAQ:ISRG) Vs The Rest Of The Pack (StockStory)
10:59AM	Is Becton, Dickinson and Company Stock Outperforming the Dow? (Barchart)
Feb-27-26 12:43PM	Clover Health Q4 Earnings Meet Estimates, Sales Beat, Membership Rises (Zacks)
12:38PM	CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash (Zacks)
12:37PM	GEHC & UCSF Form 10-Year Alliance to Advance Imaging & Care Delivery (Zacks)
09:40AM	XRAY Stock Gains Despite Q4 Earnings Miss on Restructuring Initiative (Zacks)
07:42AM	TFX Q4 Earnings & Revenues Miss, Margins Down, Stock Up in After-Market (Zacks)
Feb-26-26 11:46AM	GEHC Unveils AI LOGIQ Ultrasound Systems to Boost Imaging & Workflow (Zacks)
11:22AM	Veracyte Q4 Earnings Beat Estimates, Revenues Grow Y/Y, Stock Rises (Zacks)
11:21AM	A Decade From Now, You'll Regret Not Buying This 1 Small-Cap Stock (Barchart)
11:21AM	Intuitive Surgical or Abbott: Which MedTech Stock Is a Better Bet Now? (Zacks)
Feb-25-26 01:55PM	Merit Medical Q4 Earnings & Revenues Beat Estimate, Margins Expand (Zacks)
01:55PM	FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand (Zacks)
11:57AM	Stryker Launches Synchfix EVT for Flexible Syndesmotic Fixation (Zacks)
11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
09:09AM	Is Intuitive Surgical Stock Underperforming the Dow? (Barchart)
08:17AM	Top Robotics Stocks Worth Investing Now for Solid Returns (Zacks)
07:50AM	Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/Y (Zacks)
07:26AM	TEM Q4 Earnings Miss, Revenues Beat, Stock Down in After-Market (Zacks)
Feb-24-26 12:40PM	BD Launches Urine Complete Cup Kit for Smarter Testing & Accuracy (Zacks)
10:11AM	The Zacks Analyst Blog Highlights Oracle, Intuitive Surgical, Analog Devices and Moving iMage Technologies (Zacks)
08:46AM	Zacks Industry Outlook Highlights Intuitive Surgical, Edwards Lifesciences and Electromed (Zacks)
08:46AM	HSIC Q4 Earnings & Revenues Beat Estimates, Margins Down (Zacks)
07:45AM	MYGN Stock Up on Q4 Earnings and Revenue Beat, Gross Margin Down (Zacks)
Feb-23-26 04:11PM	Top Research Reports for Oracle, Intuitive Surgical & Analog Devices (Zacks)
03:37PM	Da Vinci 5 Sparks Optimism Around Intuitive Surgical, Inc. (ISRG) (Insider Monkey)
12:42PM	ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation (Zacks)
08:53AM	3 Medical Instrument Stocks Banking on GenAI to Tackle Industry Woes (Zacks)
Feb-20-26 12:22PM	GE HealthCare Wins FDA Clearances for Next-Gen SIGNA MRI Portfolio (Zacks)
11:48AM	AMN Q4 Earnings Meet Estimates, Revenues Beat, Gross Margin Contracts (Zacks)
11:44AM	ITGR Shares Down Despite Q4 Earnings & Revenues Beat Estimates (Zacks)
09:11AM	TNDM Q4 Earnings & Revenues Beat Estimates, Gross Margin & Stock Up (Zacks)
Feb-19-26 12:08PM	STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years (Zacks)
11:01AM	ISRG's International Growth Outpaces US With 35% Procedure Volume (Zacks)
09:30AM	Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views? (Zacks)
08:33AM	Bio-Rad's Q4 Earnings Miss Estimates, Revenues Surpass, Stock Down (Zacks)
08:16AM	Exact Sciences Q4 Earnings Match Estimates, Revenues Beat, Stock Up (Zacks)
08:09AM	PODD Stock Up on Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
07:56AM	COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal (Zacks)
Feb-18-26 01:09PM	GEHC Expands BARDA Collaboration With $35M Boost for AI Ultrasound (Zacks)
10:53AM	Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook (Zacks)
09:51AM	SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy (Zacks)
09:48AM	Reasons to Hold HealthEquity Stock in Your Portfolio for Now (Zacks)
08:55AM	CRL Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
Feb-17-26 01:11PM	Medtronic Posts Better-Than-Expected Earnings. Heres Why the Stock Is Falling. (Barrons.com)
11:20AM	Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel (Zacks)
11:12AM	QDEL Expands Immunoassay Portfolio Via Lifotronic Supply Agreement (Zacks)
10:07AM	Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market (Zacks)
09:42AM	MDT Stock Up on Q3 Earnings and Revenue Beat, Margins Down (Zacks)
09:00AM	Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know (Zacks)
03:33AM	What Are Wall Street Analysts' Target Price for Intuitive Surgical Stock? (Barchart)
Feb-16-26 11:32AM	CareDx Reports Positive Data for AlloHeme in AML and MDS Post HCT (Zacks)
10:52AM	TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial (Zacks)
10:05AM	Bruker's Q4 Earnings Lag Estimates, Margins Contract, Stock Down (Zacks)
Feb-13-26 12:35PM	DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth (Zacks)

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Curet Myriam	EVP & Chief Medical Officer	Mar 10 '26	Option Exercise	229.39	105	24,086	105	Mar 11 01:46 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 10 '26	Sale	493.95	105	51,865	0	Mar 11 01:46 PM
MYRIAM CURET MCADAMS	Officer	Mar 10 '26	Proposed Sale	493.95	105	51,865		Mar 10 04:47 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 06 '26	Sale	490.19	648	317,643	2,258	Mar 10 02:24 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 09 '26	Sale	485.01	645	312,831	1,613	Mar 10 02:24 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 04 '26	Sale	498.68	2,362	1,177,883	3,554	Mar 05 06:38 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 05 '26	Sale	495.20	648	320,890	2,906	Mar 05 06:38 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 03 '26	Sale	488.10	648	316,289	5,916	Mar 05 06:38 PM
MARK BROSIUS	Officer	Mar 05 '26	Proposed Sale	501.18	1,714	859,023		Mar 05 04:43 PM
BRIAN MILLER	Officer	Mar 04 '26	Proposed Sale	497.42	8,368	4,162,411		Mar 04 04:43 PM
Widman Fredrik	VP Corporate Controller	Feb 28 '26	Option Exercise	0.00	468	0	1,377	Mar 03 06:17 PM
Widman Fredrik	VP Corporate Controller	Feb 27 '26	Sale	499.71	249	124,428	909	Mar 03 06:17 PM
Widman Fredrik	VP Corporate Controller	Mar 03 '26	Sale	487.18	118	57,487	1,026	Mar 03 06:17 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 02 '26	Option Exercise	208.90	125	26,112	5,262	Mar 03 05:34 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 03 '26	Sale	487.18	4,728	2,303,387	409	Mar 03 05:34 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 02 '26	Sale	492.59	125	61,574	5,137	Mar 03 05:34 PM
MARK BROSIUS	Officer	Mar 03 '26	Proposed Sale	496.25	3,327	1,651,024		Mar 03 04:32 PM
FREDRIK WIDMAN	Officer	Mar 03 '26	Proposed Sale	487.18	118	57,487		Mar 03 04:29 PM
MYRIAM CURET MCADAMS	Officer	Mar 03 '26	Proposed Sale	487.18	4,728	2,303,387		Mar 03 04:17 PM
Jeddi Iman	SVP & GM da Vinci Platforms &	Feb 28 '26	Option Exercise	0.00	9,004	0	10,618	Mar 03 12:53 PM
GUTHART GARY S	Director	Feb 28 '26	Option Exercise	0.00	28,840	0	36,848	Mar 03 12:25 PM
Samath Jamie	EVP & CFO & Enterprise Technol	Feb 28 '26	Option Exercise	0.00	11,525	0	20,709	Mar 02 07:41 PM
LOEB GARY	EVP & Chief Legal and Complian	Feb 28 '26	Option Exercise	0.00	3,148	0	8,082	Mar 02 06:40 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Feb 28 '26	Option Exercise	0.00	11,525	0	16,410	Mar 02 05:17 PM
Rosa David J.	Chief Executive Officer (CEO)	Feb 28 '26	Option Exercise	0.00	24,918	0	249,698	Mar 02 05:02 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 28 '26	Option Exercise	0.00	9,255	0	10,719	Mar 02 04:48 PM
MYRIAM CURET MCADAMS	Officer	Mar 02 '26	Proposed Sale	492.59	125	61,574		Mar 02 04:09 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 28 '26	Option Exercise	0.00	9,380	0	9,292	Mar 02 03:41 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 27 '26	Sale	499.71	2,345	1,171,820	409	Mar 02 03:41 PM
WADORS PATRICIA L	SVP Chief Human Resources Offi	Feb 26 '26	Option Exercise	0.00	458	0	458	Feb 27 06:43 PM
WADORS PATRICIA L	SVP Chief Human Resources Offi	Feb 27 '26	Sale	499.71	220	109,936	0	Feb 27 06:43 PM
FREDRIK WIDMAN	Officer	Feb 27 '26	Proposed Sale	499.71	249	124,428		Feb 27 04:24 PM
MYRIAM CURET MCADAMS	Officer	Feb 27 '26	Proposed Sale	499.71	2,345	1,171,820		Feb 27 04:11 PM
PATRICIA WADORS	Officer	Feb 27 '26	Proposed Sale	499.71	220	109,936		Feb 27 04:09 PM
Jeddi Iman	SVP & GM da Vinci Platforms &	Feb 26 '26	Option Exercise	0.00	2,309	0	2,263	Feb 27 03:04 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Feb 26 '26	Option Exercise	0.00	2,747	0	5,679	Feb 27 02:53 PM
Samath Jamie	EVP & CFO & Enterprise Technol	Feb 26 '26	Option Exercise	0.00	3,396	0	10,295	Feb 27 02:45 PM
LOEB GARY	EVP & Chief Legal and Complian	Feb 26 '26	Option Exercise	0.00	2,442	0	5,389	Feb 27 02:36 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 26 '26	Option Exercise	0.00	4,654	0	3,549	Feb 27 02:00 PM
Widman Fredrik	VP Corporate Controller	Feb 26 '26	Option Exercise	0.00	989	0	1,346	Feb 27 01:52 PM
Rosa David J.	Chief Executive Officer (CEO)	Feb 26 '26	Option Exercise	0.00	6,105	0	233,783	Feb 27 01:42 PM
GUTHART GARY S	Director	Feb 26 '26	Option Exercise	0.00	8,393	0	10,954	Feb 27 01:32 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 26 '26	Option Exercise	0.00	2,595	0	2,382	Feb 27 01:19 PM
BRIAN MILLER	Officer	Feb 18 '26	Proposed Sale	493.35	647	319,197		Feb 18 04:37 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 10 '26	Option Exercise	25.54	943	24,086	1,247	Feb 11 05:37 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 11 '26	Sale	494.96	421	208,378	409	Feb 11 05:37 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 10 '26	Sale	494.65	105	51,938	830	Feb 11 05:37 PM
Widman Fredrik	VP Corporate Controller	Feb 10 '26	Option Exercise	0.00	567	0	1,095	Feb 11 05:17 PM
Widman Fredrik	VP Corporate Controller	Feb 11 '26	Sale	494.96	133	65,830	660	Feb 11 05:17 PM
FREDRIK WIDMAN	Officer	Feb 11 '26	Proposed Sale	494.96	133	65,830		Feb 11 04:05 PM
MYRIAM CURET MCADAMS	Officer	Feb 11 '26	Proposed Sale	494.96	421	208,378		Feb 11 04:02 PM
Rosa David J.	Chief Executive Officer (CEO)	Feb 10 '26	Option Exercise	0.00	1,436	0	230,294	Feb 10 04:28 PM
GUTHART GARY S	Director	Feb 10 '26	Option Exercise	0.00	2,633	0	6,327	Feb 10 04:18 PM
MYRIAM CURET MCADAMS	Officer	Feb 10 '26	Proposed Sale	494.65	105	51,938		Feb 10 04:04 PM
LOEB GARY	EVP & Chief Legal and Complian	Feb 10 '26	Option Exercise	0.00	315	0	3,876	Feb 10 03:51 PM
Jeddi Iman	SVP & GM da Vinci Platforms &	Feb 10 '26	Option Exercise	0.00	838	0	894	Feb 10 03:26 PM
Samath Jamie	EVP & CFO & Enterprise Technol	Feb 10 '26	Option Exercise	0.00	1,077	0	8,295	Feb 10 03:16 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Feb 10 '26	Option Exercise	0.00	1,077	0	4,189	Feb 10 02:16 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 10 '26	Option Exercise	0.00	838	0	1,025	Feb 10 01:54 PM
Curet Myriam	EVP & Chief Medical Officer	Jan 29 '26	Option Exercise	208.90	126	26,321	126	Jan 30 09:16 PM
Curet Myriam	EVP & Chief Medical Officer	Jan 29 '26	Sale	520.02	126	65,523	0	Jan 30 09:16 PM
MYRIAM CURET MCADAMS	Officer	Jan 29 '26	Proposed Sale	520.02	126	65,523		Jan 29 04:01 PM
Curet Myriam	EVP & Chief Medical Officer	Jan 27 '26	Option Exercise	218.25	230	50,198	125	Jan 28 04:34 PM
Curet Myriam	EVP & Chief Medical Officer	Jan 27 '26	Sale	532.61	230	122,500	0	Jan 28 04:34 PM
GUTHART GARY S	Director	Jan 27 '26	Option Exercise	174.26	25,500	4,443,546	28,194	Jan 28 04:20 PM
GUTHART GARY S	Director	Jan 27 '26	Sale	530.10	24,500	12,987,403	3,694	Jan 28 04:20 PM
GUTHART GARY S	Director	Jan 27 '26	Sale	531.52	2,800	1,488,269	15,720	Jan 28 04:20 PM
GARY S GUTHART	Officer	Jan 27 '26	Proposed Sale	530.10	24,500	12,987,403		Jan 27 05:18 PM
MYRIAM CURET MCADAMS	Officer	Jan 27 '26	Proposed Sale	532.61	230	122,500		Jan 27 04:01 PM
GUTHART GARY S	Officer	Jan 27 '26	Proposed Sale	531.52	2,800	1,488,269		Jan 27 11:11 AM
Brosius Mark	See Remarks	Dec 15 '25	Sale	548.49	464	254,499	131	Dec 17 06:59 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Dec 12 '25	Option Exercise	79.64	4,500	358,370	5,407	Dec 15 06:52 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Dec 12 '25	Sale	547.36	4,500	2,463,120	907	Dec 15 06:52 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Dec 15 '25	Sale	548.49	464	254,499	443	Dec 15 06:52 PM
MARK BROSIUS	Officer	Dec 12 '25	Proposed Sale	547.36	5,276	2,887,871		Dec 12 04:19 PM
Curet Myriam	EVP & Chief Medical Officer	Dec 10 '25	Option Exercise	229.39	104	23,857	104	Dec 10 06:23 PM
Curet Myriam	EVP & Chief Medical Officer	Dec 10 '25	Sale	559.90	104	58,230	0	Dec 10 06:23 PM
MYRIAM CURET MCADAMS	Officer	Dec 10 '25	Proposed Sale	559.90	104	58,230		Dec 10 04:01 PM
Curet Myriam	EVP & Chief Medical Officer	Dec 01 '25	Option Exercise	208.90	125	26,112	125	Dec 02 04:16 PM
Curet Myriam	EVP & Chief Medical Officer	Dec 01 '25	Sale	568.99	125	71,124	0	Dec 02 04:16 PM
GUTHART GARY S	Executive Chair of the Board o	Dec 01 '25	Option Exercise	139.52	25,500	3,557,760	25,500	Dec 02 12:50 PM
GUTHART GARY S	Executive Chair of the Board o	Dec 01 '25	Sale	570.89	22,806	13,019,722	2,694	Dec 02 12:50 PM
GARY S GUTHART	Officer	Dec 01 '25	Proposed Sale	570.89	22,806	13,019,722		Dec 01 04:48 PM
MYRIAM CURET MCADAMS	Officer	Dec 01 '25	Proposed Sale	568.99	125	71,124		Dec 01 04:05 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Nov 12 '25	Option Exercise	229.95	9,000	2,069,552	10,688	Nov 13 01:55 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Nov 12 '25	Sale	580.00	13,731	7,963,980	3,056	Nov 13 01:55 PM
BARRATT CRAIG H	Director	Nov 12 '25	Option Exercise	71.32	750	53,492	750	Nov 13 01:46 PM
BARRATT CRAIG H	Director	Nov 12 '25	Sale	580.00	750	435,000	0	Nov 13 01:46 PM
HENRY CHARLTON	Officer	Nov 12 '25	Proposed Sale	580.00	13,731	7,963,980		Nov 12 04:04 PM
CRAIG H BARRATT	Director	Nov 12 '25	Proposed Sale	580.00	750	435,000		Nov 12 04:01 PM
Curet Myriam	EVP & Chief Medical Officer	Nov 10 '25	Option Exercise	229.39	105	24,086	105	Nov 12 02:12 PM
Curet Myriam	EVP & Chief Medical Officer	Nov 10 '25	Sale	560.00	105	58,800	0	Nov 12 02:12 PM
Miller Brian Edward	EVP & Chief Digital Officer	Nov 10 '25	Option Exercise	216.50	3,500	757,746	7,960	Nov 12 02:03 PM
Miller Brian Edward	EVP & Chief Digital Officer	Nov 10 '25	Sale	575.00	3,500	2,012,500	5,758	Nov 12 02:03 PM
BRIAN MILLER	Officer	Nov 10 '25	Proposed Sale	575.00	3,500	2,012,500		Nov 10 06:18 PM
MYRIAM CURET MCADAMS	Officer	Nov 10 '25	Proposed Sale	560.00	105	58,800		Nov 10 04:01 PM
Widman Fredrik	VP Corporate Controller	Nov 05 '25	Option Exercise	75.65	2,067	156,368	2,381	Nov 06 02:17 PM
Widman Fredrik	VP Corporate Controller	Nov 05 '25	Sale	550.00	2,067	1,136,850	473	Nov 06 02:17 PM
FREDRIK WIDMAN	Officer	Nov 05 '25	Proposed Sale	550.00	2,067	1,136,850		Nov 05 04:36 PM
Curet Myriam	EVP & Chief Medical Officer	Oct 28 '25	Option Exercise	234.27	7,562	1,771,513	5,383	Oct 29 07:48 PM

Open in Screener

CAMP

CAMP4 Therapeutics Corp

Apr 20 • 04:00PM ET

4.51

+0.02 0.45 %

Healthcare • Biotechnology • USA • NASD

CAMP CAMP4 Therapeutics Corp daily Stock Chart

Held by: VTI VXF IWC

Index	-	P/E	-	EPS (ttm)	-2.57	Insider Own	60.40%	Shs Outstand	51.90M	Perf Week	-2.80%
Market Cap	234.16M	Forward P/E	-	EPS next Y	-0.72	Insider Trans	0.00%	Shs Float	20.56M	Perf Month	-12.60%
Enterprise Value	125.27M	PEG	-	EPS next Q	-0.21	Inst Own	51.21%	Short Float	2.01%	Perf Quarter	-19.75%
Income	-80.40M	P/S	66.90	EPS this Y	70.59%	Inst Trans	26.12%	Short Ratio	2.20	Perf Half Y	45.02%
Sales	3.50M	P/B	4.91	EPS next Y	7.15%	ROA	-82.00%	Short Interest	0.41M	Perf YTD	-26.43%
Book/sh	0.92	P/C	2.11	EPS next 5Y	38.25%	ROE	-145.07%	52W High	7.75 -41.81%	Perf Year	127.78%
Cash/sh	2.14	P/FCF	-	EPS past 3/5Y	-5.31% -	ROIC	-162.79%	52W Low	1.30 245.59%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	53.14%	Volatility	9.10% 8.64%	Perf 5Y	-
Dividend TTM	-	EV/Sales	35.79	EPS Y/Y TTM	0.75%	Oper. Margin	-1488.31%	ATR (14)	0.45	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.35	Sales Y/Y TTM	436.50%	Profit Margin	-2298.54%	RSI (14)	47.36	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	7.35	EPS Q/Q	-17.75%	SMA20	0.08%	Beta	0.32	Target Price	8.00
Payout	-	Debt/Eq	0.04	Sales Q/Q	-46.63%	SMA50	-2.69%	Rel Volume	0.37	Prev Close	4.49
Employees	48	LT Debt/Eq	0.04	Earnings	Mar 05 AMC	SMA200	22.47%	Avg Volume	188.20K	Price	4.51
IPO	Oct 11, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	-81.82% -29.99%	Trades		Volume	70,535	Change	0.45%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-14-26	Initiated	Rodman & Renshaw	Buy	$7
Oct-02-25	Initiated	Cantor Fitzgerald	Overweight	$7
Sep-16-25	Downgrade	JP Morgan	Overweight → Neutral
May-27-25	Initiated	Wedbush	Outperform	$8
Nov-05-24	Initiated	William Blair	Outperform
Nov-05-24	Initiated	Piper Sandler	Overweight	$18
Nov-05-24	Initiated	JP Morgan	Overweight	$23

Apr-17-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-24-26 07:00AM	CAMP4 Appoints Michael MacLean to its Board of Directors (GlobeNewswire)
Mar-06-26 04:05PM	CAMP4 to Participate in Upcoming Investor Conferences (GlobeNewswire) -8.50% +49.40%
Mar-05-26 04:05PM	CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights (GlobeNewswire) +12.50%
Feb-20-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
04:05PM	Loading…
Jan-16-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -21.00%
Jan-13-26 12:00PM	CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's Why (Zacks)
Jan-06-26 08:00AM	CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-02-26 03:22PM	Getty Images, Torm, and More Stocks See Action From Activist Investors (Barrons.com)
Dec-19-25 06:01AM	Novo files for CagriSema approval; Merck and Pfizers trial win (BioPharma Dive)
Dec-18-25 07:10AM	CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock (GlobeNewswire) -12.90%
07:00AM	CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries (GlobeNewswire)
Dec-12-25 04:05PM	CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.99%
Nov-14-25 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-06-25 04:05PM	CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) +6.97%
02:09PM	Loading…
Oct-14-25 02:09PM	3 Healthcare Companies Insiders Are Buying (MarketBeat) -6.63%
Oct-01-25 08:00AM	CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 (GlobeNewswire)
Sep-25-25 12:00PM	CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know (Zacks) +7.53%
Sep-17-25 09:40AM	Apple initiated, Hershey upgraded: Wall Streets top analyst calls (TipRanks) -6.50%
Sep-16-25 09:35AM	Apple initiated, Hershey upgraded: Wall Street's top analyst calls (The Fly)
Sep-10-25 07:00AM	CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders (GlobeNewswire) +40.20%
Aug-14-25 04:05PM	CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) +6.16% +7.74%
Jun-30-25 08:00AM	Sequans Appoints Jason W. Cohenour to Board of Directors (Newsfile)
May-16-25 06:00AM	CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire) +9.52%
May-13-25 04:05PM	CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) -7.92%
Apr-28-25 04:30PM	CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire) -10.00% -5.15%
Apr-05-25 11:00AM	Markets Watch Out For Core CPI With Big Banks Set To Report Earnings (Seeking Alpha)
Mar-27-25 04:05PM	CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -10.16%
Mar-18-25 08:00AM	CAMP4 Appoints Multiple Industry Veterans to its Board of Directors (GlobeNewswire)
Mar-04-25 05:24AM	CAMP4 Therapeutics Corporation (CAMP): Among Penny Stocks with Insider Buying in 2025 (Insider Monkey) -5.27%
08:00AM	Loading…
Feb-06-25 08:00AM	CAMP4 to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.95%
Jan-13-25 08:00AM	CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-07-25 04:05PM	CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones (GlobeNewswire)
Dec-10-24 08:00AM	CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors (GlobeNewswire) -8.08%
Dec-02-24 08:00AM	CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +5.85%
Nov-21-24 04:05PM	CAMP4 Reports Third Quarter 2024 Financial Results (GlobeNewswire) +8.44% -6.40%
Oct-10-24 07:07PM	CAMP4 Announces Pricing of Initial Public Offering (GlobeNewswire)

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
5AM Partners VI, LLC	10% Owner	Sep 11 '25	Buy	1.53	2,941,176	4,499,999	2,941,176	Sep 15 08:12 PM
Polaris Management Co. VII, L.	10% Owner	Sep 11 '25	Buy	1.53	1,307,189	1,999,999	2,825,500	Sep 11 04:59 PM
Nashat Amir	Director	Sep 11 '25	Buy	1.53	1,307,189	1,999,999	2,825,500	Sep 11 04:48 PM
Maricich Yuri	Chief Medical Officer	Sep 11 '25	Buy	1.65	6,060	9,999	6,060	Sep 11 04:25 PM
Gold Kelly	Chief Financial Officer	Sep 11 '25	Buy	1.65	6,060	9,999	67,877	Sep 11 04:24 PM
Mandel-Brehm Josh	Chief Executive Officer	Sep 11 '25	Buy	1.65	6,060	9,999	278,417	Sep 11 04:23 PM
Young Richard A	Director	Sep 11 '25	Buy	1.65	15,151	24,999	170,010	Sep 11 04:22 PM

ISRG

Intuitive Surgical Inc

CAMP

CAMP4 Therapeutics Corp

Upgrade your Finviz experience